Core Medical Publishing
Home About Us Products & Services
Frequently Asked Questions Contact Us Privacy Policy
Publishing
Core Evidence
Editorial
Aims and Scope
Features and Benefits
Online Early
Current Issue
Previous Issues
Future Issues
Free Trial
Subscribe
Permissions and Reprints
Editorial Information
Call For Papers
Continuing Medical Education
New CME Activities
MedicVision
MedicVision
Current Issue Current Issue
Core Evidence
Vol. 2, No. 4
July, 2008
ISSN: 1555-1741
Free Trial
Free Trial
Sample
Sample
Online Early

Vol 3 (1), 2008 (ISSN: 1555-1751)

Contents
bullet Ivabradine: the evidence of its therapeutic impact in angina
bullet Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
bullet Tolvaptan: the evidence for its therapeutic value in acute heart
failure syndrome
bullet Prucalopride: the evidence for its use in the treatment
of chronic constipation
bullet Omalizumab: the evidence for its place in the treatment
of allergic asthma

Vol 3 (2), 2008 (ISSN: 1555-1751)

Contents
bullet Temozolomide: the evidence for its therapeutic efficacy in
malignant astrocytomas
bullet Eptifibatide: the evidence for its role in the management of acute coronary syndromes
bullet Agomelatine: the evidence for its place in the treatment
of depression
bullet Exforge® (amlodipine/valsartan combination) in hypertension:
the evidence of its therapeutic impact
bullet Etravirine (TMC-125): the evidence for its place in the treatment
of HIV-1 infection
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Alternatively, to subscribe to Core Evidence, please click here
HOME  |  ABOUT US   |  PRODUCTS & SERVICES  |  FAQ  |  CONTACT US  |  PRIVACY POLICY
| Terms and conditions